<DOC>
	<DOCNO>NCT00345033</DOCNO>
	<brief_summary>This study evaluate effect combination treatment aripiprazole clozapine insulin resistance , blood fat level , weight gain people diagnose schizophrenia .</brief_summary>
	<brief_title>Effectiveness Aripiprazole Improving Side Effects Clozapine Treatment People With Schizophrenia</brief_title>
	<detailed_description>Schizophrenia severely disable brain disorder . People schizophrenia often experience hallucination delusion , well overall difficulty everyday function . Although medication available treat disorder generally effective , many cause undesirable side effect . Clozapine , example , strong tranquilizer function like antipsychotic medication . It show effective reducing symptom schizophrenia , bring serious side effect , include heart failure , weight gain , diabetes . Aripiprazole , atypical antipsychotic medication , show few side effect older antipsychotic drug . The addition aripiprazole clozapine treatment regimen may reduce negative side effect clozapine . This study evaluate effect combination treatment aripiprazole clozapine insulin resistance , blood fat level , weight gain people schizophrenia . Individuals interested participate 8-week , double-blind study first attend screen session study site . Medical psychiatric evaluation complete , blood sample take , EKG perform . Eligible participant undergo baseline assessment randomly assign receive either aripiprazole placebo addition prescribe dose clozapine . Participants take one 15-mg capsule assign medication day 8 week . Study visit occur biweekly first 8 week , follow one final follow-up visit Week 12 . At study visit , medication distribute , follow criterion assess : vital sign ; weight ; complete blood count ; medication side effect ; extrapyramidal symptom ( EPS ) , potential neurological side effect antipsychotic medication may include involuntary movement , tremor , rigidity . The Week 8 visit include EKG , assessments follow criterion : vital sign ; medication side effect ; treatment efficacy ; blood count ; weight height ; waist hip circumference . At baseline Week 8 , participant also undergo frequently sample intravenous glucose tolerance test ( FSIVGTT ) . This involve intravenous infusion glucose follow frequent blood sample measure insulin glucose concentration . During 4 day prior FSIVGTT , participant record food intake wear activity monitor .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Diagnosis schizophrenia ( subtype ) schizoaffective disorder ( subtype ) Treatment clozapine least 1 year Stable dose clozapine least 1 month Well establish compliance outpatient medication Female participant nonchildbearing potential childbearing potential willing practice appropriate birth control method ( complete abstinence sexual intercourse , female sterilization , sterilization male partner , implant levonorgestrel , injectable progestogen , oral contraceptive , intrauterine device , double barrier method contraception use spermicide either condom diaphragm ) study Current substance abuse Psychiatrically unstable Significant medical illness , include severe cardiovascular , hepatic , renal disease History immunosuppression Current recent radiation chemotherapy treatment cancer Chronic use steroid Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Glucose Metabolism</keyword>
</DOC>